Osaka, Japan

Hideto Fujiwara

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Otsuka Pharmaceutical Company, Limited, Taiho Pharmaceutical Company Limited. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideto Fujiwara. Retrieved from https://idiyas.com/inventor/hideto-fujiwara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 11.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Cambridge, GB (2022)
  • Osaka, JP (2021 - 2023)

Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hideto Fujiwara

Introduction

Hideto Fujiwara, a prominent inventor located in Osaka, Japan, has made significant strides in the field of pharmaceuticals. With three patents to his name, his work mainly focuses on developing novel compounds with substantial medical applications.

Latest Patents

Among Hideto Fujiwara's latest patents is one involving benzazepine derivatives. This invention presents novel benzazepine compounds that exhibit vasopressin V and V antagonist properties, along with various medical uses. The compounds are defined by a specific formula where R can be substituted with alkyl groups, and various hydrocarbon rings may hold substituents. Another notable patent features new pyrazine derivatives, where the compounds are designed for use in pharmaceutical compositions that treat diseases like cancer. These innovations exemplify his dedication to advancing medical science through chemistry.

Career Highlights

Hideto Fujiwara has had an impressive career, working with notable companies such as Otsuka Pharmaceutical Company Limited and Taiho Pharmaceutical Company Limited. His experiences with these leading pharmaceutical enterprises have undoubtedly enriched his expertise and fostered his inventive spirit in the realm of pharmaceuticals.

Collaborations

Throughout his career, Hideto has collaborated with esteemed colleagues like Keizo Kan and Masatoshi Takuwa. These partnerships have been integral to his projects, enabling the exchange of ideas and driving innovative solutions in their field.

Conclusion

Hideto Fujiwara stands out as an influential figure in the world of pharmaceuticals, with a robust portfolio of patents and collaborations. His contributions, particularly in the development of benzazepine and pyrazine derivatives, reflect a commitment to improving health outcomes through innovative chemical solutions. His work serves as an inspiring example of how inventors can drive progress in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…